Extendicare Inc
TSX:EXE

Watchlist Manager
Extendicare Inc Logo
Extendicare Inc
TSX:EXE
Watchlist
Price: 22.83 CAD 0.18% Market Closed
Market Cap: 1.9B CAD

Wall Street
Price Targets

EXE Price Targets Summary
Extendicare Inc

Wall Street analysts forecast EXE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EXE is 23.72 CAD with a low forecast of 19.19 CAD and a high forecast of 26.25 CAD.

Lowest
Price Target
19.19 CAD
16% Downside
Average
Price Target
23.72 CAD
4% Upside
Highest
Price Target
26.25 CAD
15% Upside
Extendicare Inc Competitors:
Price Targets
TOI
Oncology Institute Inc
89% Upside
RAINBOW
Rainbow Children's Medicare Ltd
19% Upside
2219
Chaoju Eye Care Holdings Ltd
49% Upside
4005
National Medical Care Company JSC
0% Upside
HCG
Healthcare Global Enterprises Ltd
15% Upside
BH
Bumrungrad Hospital PCL
31% Upside
THC
Tenet Healthcare Corp
19% Upside
MEDANTA
Global Health Ltd
25% Upside

Revenue
Forecast

Revenue Estimate
Extendicare Inc

For the last 13 years the compound annual growth rate for Extendicare Inc's revenue is -3%. The projected CAGR for the next 3 years is 14%.

-3%
Past Growth
14%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Extendicare Inc

For the last 13 years the compound annual growth rate for Extendicare Inc's operating income is -1%. The projected CAGR for the next 3 years is 27%.

-1%
Past Growth
27%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Extendicare Inc

The compound annual growth rate of Extendicare Inc's net income for the next 3 years is 15%.

N/A
Past Growth
15%
Estimated Growth
Estimates Accuracy
40%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EXE's stock price target?
Price Target
23.72 CAD

According to Wall Street analysts, the average 1-year price target for EXE is 23.72 CAD with a low forecast of 19.19 CAD and a high forecast of 26.25 CAD.

What is Extendicare Inc's Revenue forecast?
Projected CAGR
14%

For the last 13 years the compound annual growth rate for Extendicare Inc's revenue is -3%. The projected CAGR for the next 3 years is 14%.

What is Extendicare Inc's Operating Income forecast?
Projected CAGR
27%

For the last 13 years the compound annual growth rate for Extendicare Inc's operating income is -1%. The projected CAGR for the next 3 years is 27%.

What is Extendicare Inc's Net Income forecast?
Projected CAGR
15%

The compound annual growth rate of Extendicare Inc's net income for the next 3 years is 15%.

Back to Top